Mathieu Anheim Selected Research

autosomal recessive 1 Spinocerebellar ataxia

12/2020	Autosomal Recessive Cerebellar Ataxias With Elevated Alpha-Fetoprotein: Uncommon Diseases, Common Biomarker.
1/2018	Clinical, Biomarker, and Molecular Delineations and Genotype-Phenotype Correlations of Ataxia With Oculomotor Apraxia Type 1.
7/2008	Clinical and molecular findings of ataxia with oculomotor apraxia type 2 in 4 families.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mathieu Anheim Research Topics

Disease

11	Cerebellar Ataxia (Dysmetria) 01/2022 - 03/2008
11	Ataxia (Dyssynergia) 05/2021 - 03/2008
10	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2007
9	Parkinsonian Disorders (Parkinsonism) 01/2022 - 01/2007
5	Dyskinesias (Dyskinesia) 01/2022 - 01/2011
4	Movement Disorders (Movement Disorder) 01/2022 - 10/2013
4	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2021 - 01/2017
3	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2022 - 04/2012
3	Spinocerebellar Degenerations (Marinesco Sjogren Syndrome) 01/2022 - 01/2018
3	COVID-19 08/2021 - 01/2020
3	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 01/2021 - 12/2018
3	autosomal recessive 1 Spinocerebellar ataxia 12/2020 - 07/2008
3	Hereditary Spastic Paraplegia 10/2020 - 05/2015
3	Tremor (Tremors) 11/2012 - 01/2009
2	Multiple System Atrophy 01/2022 - 01/2022
2	Chorea (Rheumatic Chorea) 10/2021 - 02/2011
2	Infections 10/2021 - 11/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 06/2015
2	Intellectual Disability (Idiocy) 01/2020 - 02/2014
2	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 10/2018 - 05/2017
2	Apraxias (Dyspraxia) 01/2018 - 07/2008
2	Channelopathies 06/2017 - 11/2015
2	Fragile X Tremor Ataxia Syndrome 01/2017 - 10/2012
2	Paraplegia (Spastic Paraplegia) 09/2015 - 05/2015
2	Coenzyme Q10 Deficiency 10/2013 - 03/2008
2	Atrophy 10/2012 - 07/2008
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2022
1	Mania (Manias) 01/2022
1	Dizziness (Lightheadedness) 01/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022
1	Beta-Hydroxyisobutyryl CoA Deacylase Deficiency 10/2021
1	Leigh Disease (Leigh's Disease) 10/2021
1	Critical Illness (Critically Ill) 08/2021
1	Respiratory Insufficiency (Respiratory Failure) 08/2021
1	Hypoxia (Hypoxemia) 08/2021
1	Renal Insufficiency (Renal Failure) 08/2021
1	Diplopia (Double Vision) 04/2021
1	Medulloblastoma 01/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2020
1	Mental Disorders (Mental Disorder) 11/2020
1	Neurologic Manifestations (Neurological Manifestations) 11/2020
1	Dementia (Dementias) 10/2020
1	Polymicrogyria 10/2020
1	Autonomic Nervous System Diseases (Dysautonomia) 10/2020
1	Disease Progression 01/2020
1	Muscle Hypotonia (Hypotonia) 01/2020
1	Neurodevelopmental Disorders 01/2020
1	Dystonic Disorders (Writer's Cramp) 01/2020
1	Autism Spectrum Disorder 01/2020
1	Epilepsy (Aura) 01/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020
1	Dystonia (Limb Dystonia) 01/2020
1	Delirium 01/2020
1	Tourette Syndrome (Tourette's Syndrome) 01/2019

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2012
8	Levodopa (L Dopa)FDA LinkGeneric 11/2020 - 01/2007
6	Proteins (Proteins, Gene)FDA Link 05/2021 - 06/2012
3	Dopamine Agonists (Dopamine Agonist)IBA 01/2022 - 12/2018
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2021 - 07/2008
3	LipidsIBA 01/2021 - 05/2017
3	coenzyme Q10 (CoQ10)IBA 01/2020 - 03/2008
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 06/2012
3	polyglutamineIBA 06/2017 - 04/2012
2	IronIBA 10/2020 - 01/2017
2	Opioid Receptors (Opioid Receptor)IBA 01/2019 - 12/2018
2	Fetal Proteins (Fetoprotein)IBA 01/2018 - 09/2014
2	CalciumIBA 11/2015 - 12/2010
2	UbiquinoneIBA 10/2013 - 03/2008
1	Dopamine (Intropin)FDA LinkGeneric 01/2022
1	PhosphoproteinsIBA 01/2022
1	Riluzole FDA LinkGeneric 01/2022
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2022
1	Apomorphine FDA Link 01/2022
1	Clozapine (Clozaril)FDA LinkGeneric 01/2022
1	Caffeine (No Doz)FDA LinkGeneric 01/2022
1	Valine (L-Valine)FDA Link 10/2021
1	Oxidoreductases (Dehydrogenase)IBA 10/2021
1	Pyruvic Acid (Pyruvate)IBA 10/2021
1	HydrolasesIBA 10/2021
1	Uremic ToxinsIBA 08/2021
1	CreatinineIBA 08/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Oxygen (Dioxygen)IBA 11/2020
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2020
1	Adaptor Protein Complex 4IBA 10/2020
1	Clonidine (ST 155)FDA LinkGeneric 03/2020
1	Member 2 Group A Nuclear Receptor Subfamily 4IBA 01/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020
1	AcidsIBA 01/2020
1	miglustat (Zavesca)FDA Link 10/2018
1	SolutionsIBA 10/2018
1	Serum AlbuminIBA 01/2018

Therapy/Procedure

5	Therapeutics 01/2021 - 10/2013
2	Denervation 01/2022 - 01/2022
2	Deep Brain Stimulation 01/2022 - 01/2021
2	Length of Stay 04/2021 - 01/2020
1	Extracorporeal Membrane Oxygenation 08/2021
1	Telescopes 04/2021
1	Activities of Daily Living (ADL) 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2020